[RNAZ] QoQ Quarter Result on 30-Jun-2021 [#Q2]

Stock
[RNAZ] TransCode Therapeutics, Inc.
Announcement Date
23-Aug-2021
Financial Year
2021
Quarter
30-Jun-2021 [#Q2]
Profit Trend
QoQ- 231.48%
YoY- 4,743.31%
Quarter Report
RNAZ's Result
RNAZ's Financial Summary
View:
Show?
Quarter Result
31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 CAGR
Revenue 0 0 0 0 0 0 0 -
PBT -3,470 -5,910 -2,330 2,771 -4,485 -802 -1,374 85.55%
Tax -7 2,924 -30 -3,126 3,983 369 854 -
NP -3,463 -8,834 -2,300 5,897 -4,485 -802 -1,374 85.30%
Tax Rate - - - 112.83% - - - -
Total Cost 3,463 8,834 2,300 -5,897 4,485 802 1,374 85.30%
Ratio Analysis
31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 CAGR
EPS -216.41 -552.15 -164.25 589.73 -278.07 -100.46 -172.19 16.47%
EPS Diluted -213.45 -547.70 -159.60 589.73 -278.07 -100.46 -172.19 15.41%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.